Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents01:18

Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents

264
Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
264
Gene Regulation in Microbial Communities: Quorum Sensing01:28

Gene Regulation in Microbial Communities: Quorum Sensing

178
Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
178
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

670
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
670

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Zinc-based cyclens containing pyridine and cross-bridges: X-ray and DFT structures, Lewis acidity, gas-phase acidity, and p<i>K</i> <sub>a</sub> values.

Polyhedron·2026
Same author

Long-Lived Photochromism in a Crystalline Hybrid Naphthalenediimide-Polyoxovanadate System.

Inorganic chemistry·2026
Same author

Structure of core assembly of the Clostridioides difficile germinosome.

Nature communications·2026
Same author

A Lactone-Enabled Approach to Metronidazole-Based Scaffolds.

The Journal of organic chemistry·2026
Same author

Outer Membrane-Peptidoglycan Anchoring in <i>Pseudomonas aeruginosa</i>.

Journal of the American Chemical Society·2026
Same author

Hydrochlorides, hydrates, hydronitrate, and an unanticipated hydrolysis product of famotidine.

Acta crystallographica. Section C, Structural chemistry·2026

Related Experiment Video

Updated: Nov 1, 2025

A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment
12:58

A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment

Published on: May 25, 2017

9.2K

Structure-Activity Relationship for the Picolinamide Antibacterials that Selectively Target Clostridioides difficile.

Enrico Speri1, Yuanyuan Qian1, Jeshina Janardhanan1

  • 1Department of Chemistry and Biochemistry, University of Notre Dame, Notre Dame, Indiana 46556, United States.

ACS Medicinal Chemistry Letters
|June 18, 2021
PubMed
Summary

New picolinamide antibacterials selectively target Clostridioides difficile (C. difficile), a major health threat. This discovery offers hope for treating recurrent C. difficile infections without disrupting gut microbiota.

More Related Videos

Metabolic Profiling to Determine Bactericidal or Bacteriostatic Effects of New Natural Products using Isothermal Microcalorimetry
07:28

Metabolic Profiling to Determine Bactericidal or Bacteriostatic Effects of New Natural Products using Isothermal Microcalorimetry

Published on: October 29, 2020

8.9K
Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291
06:51

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291

Published on: December 10, 2016

12.9K

Related Experiment Videos

Last Updated: Nov 1, 2025

A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment
12:58

A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment

Published on: May 25, 2017

9.2K
Metabolic Profiling to Determine Bactericidal or Bacteriostatic Effects of New Natural Products using Isothermal Microcalorimetry
07:28

Metabolic Profiling to Determine Bactericidal or Bacteriostatic Effects of New Natural Products using Isothermal Microcalorimetry

Published on: October 29, 2020

8.9K
Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291
06:51

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291

Published on: December 10, 2016

12.9K

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Medicinal Chemistry

Background:

  • Clostridioides difficile (C. difficile) infections are a significant health concern, often occurring after antibiotic use disrupts the gut microbiota.
  • C. difficile spores are resistant to antibiotics, complicating treatment and leading to recurrent infections.
  • Current treatments lack selectivity, harming beneficial gut bacteria and necessitating new therapeutic strategies.

Purpose of the Study:

  • To discover novel antibiotics with potent and selective activity against C. difficile.
  • To investigate the structure-activity relationship of picolinamide derivatives for improved C. difficile targeting.
  • To identify compounds that can treat recurrent C. difficile infections while preserving gut microbiota balance.

Main Methods:

  • Synthesized and evaluated 108 analogues of isonicotinamide 4, focusing on structure-activity relationships.
  • Assessed antibacterial activity against C. difficile and methicillin-resistant Staphylococcus aureus (MRSA).
  • Identified lead compounds with selective potency against C. difficile.

Main Results:

  • The picolinamide core, exemplified by analogue 87, demonstrated potent and selective activity against C. difficile.
  • Unlike isonicotinamide 4, which targets both C. difficile and MRSA, picolinamide derivatives showed enhanced selectivity for C. difficile.
  • The developed compounds effectively target C. difficile without causing significant gut dysbiosis.

Conclusions:

  • Picolinamide antibacterials represent a promising new class of drugs for treating C. difficile infections.
  • Their selective action against C. difficile offers a potential solution for recurrent infections and antibiotic-induced gut dysbiosis.
  • This research paves the way for developing safer and more effective therapies against this critical pathogen.